98%
921
2 minutes
20
Sluggish surface reaction is a critical factor that strongly governs the efficiency of photocatalytic solar fuel production, particularly in CO-to-ethanol photoconversion. Here, inspired by the principles underlying enzyme catalytic proficiency and specificity, we report a biomimetic photocatalyst that affords superior CO-to-ethanol photoreduction efficiency (5.5 millimoles gram hour in average with 98.2% selectivity) distinctly surpassing the state of the art. The key is to create a class of catalytic pocket, which contains spatially organized NH…Cu-Se(-Zn) multiple functionalities at close range, over ZnSe colloidal quantum wells. Such structure offers a platform to mimic the concerted cooperation between the active site and surrounding secondary/outer coordination spheres in enzyme catalysis. This is manifested by the chemical adsorption and activation of CO via a bent geometry, favorable stabilization toward a variety of important intermediates, promotion of multielectron/proton transfer processes, etc. These results highlight the potential of incorporating enzyme-like features into the design of photocatalysts to overcome the challenges in CO reduction.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11578185 | PMC |
http://dx.doi.org/10.1126/sciadv.adq2791 | DOI Listing |
Biotechnol J
September 2025
Bioprocess Development Biologicals, Cell Line Development, Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany.
The use of metabolic selection markers has advanced stable cell line generation, increasing productivity while simultaneously eliminating the need for antibiotic reagents. This study explores the potential of bacterially derived glutamine synthetases (GS) as a novel generation of metabolic selection markers to further enhance CHO cell culture performance. GS-I proteins were extracted from the genomes of enterobacterial and actinomycetes species.
View Article and Find Full Text PDFHistone H3 lysine 9 (H3K9) methylation must be regulated to prevent inappropriate heterochromatin for-mation. Regulation of the conserved fission yeast H3K9 methyltransferase Clr4 (Suv39h) involves an au-tomethylation-induced conformational switch and interaction of its catalytic SET domain with mono-ubiquitinated histone H3 lysine 14 (H3K14ub), a modification catalyzed by the Cul4 subunit of the CLRC complex. Using reconstituted CLRC, we show that Clr4 catalytic pocket serves as a substrate receptor for Cul4-dependent H3K14 ubiquitination.
View Article and Find Full Text PDFCas9 is a metal-dependent nuclease that has revolutionized gene editing across diverse cells and organisms exhibiting varying ion uptake, metabolism, and concentrations. However, how divalent metals impact its catalytic function, and consequently its editing efficiency in different cells, remains unclear. Here, extensive molecular simulations, Markov State Models, biochemical and NMR experiments, demonstrate that divalent metals - Mg , Ca , and Co - promote activation of the catalytic HNH domain by binding within a dynamically forming divalent metal binding pocket (DBP) at the HNH-RuvC interface.
View Article and Find Full Text PDFOrg Lett
September 2025
School of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, China.
Current research on artificial aldolases predominantly centers on aldehyde substrates with relatively limited exploration of ketone substrates. Here, we report the creation of a novel artificial aldolase based on apo-myoglobin by embedding an organocatalytic secondary amine cofactor in the protein's distal pocket. The designer enzyme exhibits good to excellent enantioselectivities (up to 97.
View Article and Find Full Text PDFInt J Biol Macromol
September 2025
Department of Surgery of Spine and Spinal Cord, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 471003, China. Electronic address:
Background: Osteosarcoma (OS) progression is linked to kinase allostery dysregulation, but PRKX's allosteric role remains unknown. We aimed to decode PRKX's activation mechanism and assess its clinical potential as a biomarker and therapeutic target.
Methods: Differential expression analysis confirmed PRKX's oncogenic role.